Gene · 8013
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear stress bodies: a potential mechanism to shut off lethal inflammatory cytokines. | Signal Transduct Target Ther | 2025 | 41052984 | PubTator, text mining | PubMed |
| Upregulation of NR4A3 increases sensitivity to niraparib in ovarian cancer cells resistant to this drug. | J Mol Histol | 2025 | 41026279 | PubTator, text mining | PubMed |
| [Construction and verification of a prognostic model combining anoikis and immune prognostic signatures for primary liver cancer]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 41022606 | PubTator, text mining | PubMed |
| NR4A3 affects fibrotic activation of orbital fibroblasts and thyroid-associated ophthalmopathy through regulating NF-κB signaling. | J Mol Endocrinol | 2025 | 41001730 | PubTator, text mining | PubMed |
| Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy. | Stem Cells Transl Med | 2025 | 40973918 | PubTator, text mining | PubMed |
| Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity. | Front Genet | 2025 | 40969325 | PubTator, text mining | PubMed |
| Comparative Profiling and Chemogenomics Application of Chemical Tools for NR4A Nuclear Receptors. | J Med Chem | 2025 | 40968635 | PubTator, text mining | PubMed |
| The role of radiotherapy and chemotherapy in extraskeletal myxoid chondrosarcoma. | J Orthop Surg Res | 2025 | 40885991 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
| Uterine Myxoid Mesenchymal Tumor With a Novel SS18::VEZF1 Gene Fusion, Lacking Worrisome Histological Features. | Genes Chromosomes Cancer | 2025 | 40878061 | PubTator, text mining | PubMed |
| Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features. | Histopathology | 2025 | 40856424 | PubTator, text mining | PubMed |
| Hypoxia-associated genes and metabolic abnormalities in peripheral blood mononuclear cells of type 1 diabetes mellitus patients. | Hereditas | 2025 | 40836269 | PubTator, text mining | PubMed |
| Diagnosis and Management of Large Extraosseous Myxoid Chondrosarcoma of the Buttocks: A Case Report. | Am J Case Rep | 2025 | 40831041 | PubTator, text mining | PubMed |
| Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma. | Genes Chromosomes Cancer | 2025 | 40828003 | PubTator, text mining | PubMed |
| Clinicopathological and Molecular Characterization of Uterine Tumors Resembling Ovarian Sex Cord Tumors: An Eight-Case Series with Novel Fusion Gene Insights and Literature Review. | Curr Med Sci | 2025 | 40794117 | PubTator, text mining | PubMed |
| Impact of Acute Endurance Exercise on Alternative Splicing in Skeletal Muscle. | FASEB Bioadv | 2025 | 40746864 | PubTator, text mining | PubMed |
| Functional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1. | Biochem Res Int | 2025 | 40746844 | PubTator, text mining | PubMed |
| Epigenetic Age Monitoring in Professional Soccer Players for Tracking Recovery and the Effects of Strenuous Exercise. | Aging Cell | 2025 | 40726009 | PubTator, text mining | PubMed |
| Extraskeletal Myxoid Chondrosarcoma With Rhabdoid Features in a Pediatric Patient. | Cureus | 2025 | 40704268 | PubTator, text mining | PubMed |
| NR4A3 potentials M1-like macrophage polarization to facilitate anti-tumor immune responses in breast cancer. | NPJ Breast Cancer | 2025 | 40624019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8013/papers?page=4